From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy
Nenhuma Miniatura disponível
Data
2021-01-01
Autores
Criado, Paulo Ricardo
Miot, Hélio Amante [UNESP]
Pincelli, Thais Prota Hussein
Fabro, Alexandre Todorovic
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
COVID-19 generates a complex systemic inflammatory response that can lead to death due to wide macrophage activation, endothelial damage, and coagulation in critically ill patients. SARS-CoV-2-induced lung injury due to inflammatory mediated thrombosis could be similar to the livedoid vasculopathy in the skin, supporting a translational comparison of these clinical settings. In this article, we discuss anticoagulation, suppression of inflammatory response, and hyperbaric oxygen therapy in the context of severe COVID-19 and livedoid vasculopathy.
Descrição
Palavras-chave
COVID-19, heparin, hyperbaric oxygenation, livedoid, thrombosis, vasculopathy
Como citar
Dermatologic Therapy, v. 34, n. 1, 2021.